$2.64B
$132,000
0.0% of portfolio
1,000
Q2 2025
Reduced 85.71%
$7.26B
$947,000
0.0% of portfolio
3,200
Q2 2025
Reduced 21.95%
$12.3B
$317,000
0.0% of portfolio
1,807
Q2 2025
New
$247M
$213,000
0.0% of portfolio
121,200
Q2 2025
Added 7.64%
$5.9B
$60,000
0.0% of portfolio
2,505
Q2 2025
New
$4.51B
$1.17 Million
0.0% of portfolio
8,500
Q2 2025
Added 7.59%
$2.05B
$622,000
0.0% of portfolio
7,400
Q2 2025
Reduced 11.9%
$729M
$610,000
0.0% of portfolio
16,400
Q2 2025
Reduced 7.34%
$173M
$92,000
0.0% of portfolio
13,100
Q2 2025
Reduced 80.03%
$7.57B
$324,000
0.0% of portfolio
1,800
Q1 2025
Reduced 25.0%
$1.47B
$292,000
0.0% of portfolio
5,300
Q2 2024
Added 6.0%
$488M
$230,000
0.0% of portfolio
62,500
Q3 2024
Reduced 5.59%
$237M
$315,000
0.0% of portfolio
10,900
Q2 2025
New
$3.56B
$319,000
0.0% of portfolio
2,600
Q2 2025
Added 8.33%
$2.33B
$991,000
0.0% of portfolio
19,200
Q2 2025
Added 10.34%
$8.11B
$1.12 Million
0.0% of portfolio
5,000
Q2 2025
Added 6.38%
$394M
$382,000
0.0% of portfolio
10,700
Q2 2025
New
$1.86B
$400,000
0.0% of portfolio
14,600
Q1 2025
Added 14.96%
$252M
$97,000
0.0% of portfolio
12,400
Q2 2025
Added 19.23%
$221M
$502,000
0.0% of portfolio
26,000
Q2 2025
Reduced 7.14%
$917M
$556,000
0.0% of portfolio
9,300
Q2 2025
Reduced 7.92%
$3.13B
$68,000
0.0% of portfolio
2,268
Q2 2025
New
$150M
$55,000
0.0% of portfolio
76,600
Q3 2024
Reduced 5.43%
$359M
$70,000
0.0% of portfolio
7,100
Q2 2025
Added 36.54%
$2.28B
$240,000
0.0% of portfolio
13,900
Q2 2025
Reduced 10.9%
Perspective Therapeutics Inc
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 39.08%
-
$0
0.0% of portfolio
-
Q1 2025
New
$8B
$701,000
0.0% of portfolio
7,900
Q2 2025
Reduced 7.06%
-
$0
0.0% of portfolio
-
Q2 2025
Added 16.46%
-
$0
0.0% of portfolio
-
Q2 2025
Added 7.6%
$472M
$204,000
0.0% of portfolio
52,100
Q2 2025
Added 7.64%
$275M
$29,000
0.0% of portfolio
1,600
Q1 2024
Reduced 5.88%
$161M
$1,000
0.0% of portfolio
100
Q4 2024
Added 2,700.0%
$1.64B
$608,000
0.0% of portfolio
20,100
Q2 2025
Added 7.49%
$3.32B
$980,000
0.0% of portfolio
40,100
Q2 2025
Reduced 3.14%
$6.81B
$147,000
0.0% of portfolio
3,070
Q2 2025
New
$641M
$99,000
0.0% of portfolio
11,400
Q1 2024
Reduced 5.79%
$3.97B
$190,000
0.0% of portfolio
600
Q2 2025
Reduced 25.0%
$521M
$256,000
0.0% of portfolio
9,100
Q2 2025
Reduced 7.14%
$5.25B
$222,000
0.0% of portfolio
4,200
Q4 2024
Added 11.9%
$410M
$549,000
0.0% of portfolio
85,100
Q2 2025
Added 6.38%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 50.84%
$515M
$553,000
0.0% of portfolio
28,800
Q2 2025
Reduced 6.49%
$10B
$255,000
0.0% of portfolio
529
Q2 2025
New
$1.87B
$750,000
0.0% of portfolio
42,600
Q2 2025
Reduced 2.52%
$0
$297,000
0.0% of portfolio
77,100
Q2 2025
New
$3.9B
$1.14 Million
0.0% of portfolio
17,300
Q4 2024
Reduced 7.51%
$8.71B
$975,000
0.0% of portfolio
21,000
Q2 2025
Added 66.67%
-
$0
0.0% of portfolio
-
Q2 2025
New
$415M
$110,000
0.0% of portfolio
19,200
Q2 2025
Reduced 11.52%